Rhys Jones - Concepedia

Author

Rhys Jones

Also Known As

Jones, R.M., Jones, Rhys, Mathoorika Sivananthan, R M Jones, R. Jones, R. M. Jones, R.M. JONES, R.M. Jones, R. M. Jones, Rhys Jones

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (United Kingdom)University Hospital of Wales University of Maryland, Baltimore Purdue University West Lafayette

About

Rhys Jones is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	663
2	Allergy	4	4	104
3	Natural Sciences	3	3	105
4	Health Sciences	1	1	27
5	Public Health	1	1	160

Rhys Jones

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 Britton Boras, Rhys Jones, Brandon J. Anson, Nature Communications	2021	284
Smoking and Anesthesia A. C. Pearce, Rhys Jones Anesthesiology Tobacco CessationPerioperative MedicineAnalgesiaAnesthetic AdministrationTobacco Control	1984	160
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19 Britton Boras, Rhys Jones, Brandon J. Anson,	2020	158
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer Kevin D. Freeman‐Cook, Robert L. Hoffman, Douglas C. Behenna, Journal of Medicinal Chemistry	2021	112
Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses Ben Forbes, Raegan O’Lone, Philippa Pribul Allen, Advanced Drug Delivery Reviews InflammationMacrophage BiologyAsthmaLung DepositionLung Inflammation	2014	90
Patient‐controlled analgesia using remifentanil in the parturient with thrombocytopaenia Rhys Jones, A. Pegrum, R. G. W. Stacey Anaesthesia	1999	76
Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient‐controlled analgesia R. Alexander, A. T. Lovell, D. Seingry, Anaesthesia	1995	76
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide–Peptoid Hybrid CXCR7 Modulators Markus Boehm, Kevin Beaumont, Rhys Jones, Journal of Medicinal Chemistry	2017	70
Detection of epidural catheters with ultrasound in children M.S. Chawathe, Rhys Jones, C. Gildersleve, Pediatric Anesthesia	2003	65
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer Shikhar Sharma, Chi‐Yeh Chung, Sean Uryu, Cell chemical biology	2023	59

Page 1